Moteur de recherche d’entreprises européennes
Financement de l’UE (3 612 340 €) : Drug-coated balloon simulation and optimization system for the improved treatment of peripheral artery disease Hor04/09/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Drug-coated balloon simulation and optimization system for the improved treatment of peripheral artery disease
DECODE will focus on the training of young scientists on the use of drug-eluting devices to combat the burden of peripheral artery disease (PAD). DECODE will provide young researchers with excellent scientific, technological and complementary skills through a multidisciplinary training programme having as an outmost scientific aim the development, optimization, and assessment of a drug eluting balloon system for the improved treatment of PAD. The aim of DECODE is twofold: a) to enhance the competitiveness and research careers of young researchers at European level as after the completion of the programme they will be able to face current and future challenges on the domain of biomedical engineering, b) to convert knowledge, ideas and expertise from both the academic and non-academic sectors into a novel product which will improve the monitoring and treatment of patients suffering from PAD and their quality of life, providing thus a significant economic and social benefit.
| Ethniko Kai Kapodistriako Panepistimio Athinon | 715 552 € |
| Istrazivacko Razvojni Centar ZA Bioinzenjering Bioirc d.o.o. | 653 477 € |
| Medapp SA | 454 957 € |
| Panepistimio Ioanninon | 486 035 € |
| Panepistimio Patron | 243 018 € |
| Politecnico Di Milano | 784 499 € |
| Universite de Montpellier | 274 802 € |
https://cordis.europa.eu/project/id/956470
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Ethniko Kai Kapodistriako Panepistimio Athinon - Financement de l’UE (3 612 340 €) : Drug-coated balloon simulation and optimization system for the improved treatment of peripheral artery disease"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
